Your browser doesn't support javascript.
loading
Advance in research for afatinib and its analogues, the multi-target tyrosine kinase inhibitor / 中国药学杂志
Chinese Pharmaceutical Journal ; (24): 2145-2149, 2014.
Artículo en Chino | WPRIM | ID: wpr-860086
ABSTRACT

OBJECTIVE:

To review the lastest research progress afatinih and its analogues, which are multi-target tyrosine kinase inhibitor.

METHODS:

By consulting references, the synthesis afatinib, the design, synthesis and antitumor activity its analogues are summarized, the antitumor activity, structure-activity relationship, pharmacokinetic research, adverse reaction are also summarized.

RESULTS:

The research progress afatinib and its analogues was comprehensively summarized.

CONCLUSION:

Although afatinib has much adverse reaction, it still has a good prospect and its analogues may be worth further studying.

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Idioma: Chino Revista: Chinese Pharmaceutical Journal Año: 2014 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Idioma: Chino Revista: Chinese Pharmaceutical Journal Año: 2014 Tipo del documento: Artículo